Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to pinpoint safe observation time for kids after anaphylaxis

NCT ID NCT07231393

Knowledge-focused Sponsor: Aydin Adnan Menderes University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked back at the medical records of 67 children treated for anaphylaxis in a Turkish emergency department over 10 years. Researchers wanted to know how long kids were observed and how often a second wave of symptoms (biphasic reaction) occurred. They also looked for risk factors like delayed epinephrine use or asthma. The goal is to improve guidelines for safe observation times in children.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors know how long to observe children after anaphylaxis and which kids need extra monitoring.
What could go wrong
This is a small, single-center review of past records, so results may not apply to all children or emergency settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

67 people

The number who actually took part.

Start date

May 2014

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Children and adolescents (\<18 years) who presented to the Pediatric Emergency Department of Adnan Menderes University Hospital between January 1, 2014, and December 31, 2024, with a diagnosis of anaphylaxis.

Ages

0 months to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Age \<18 years * Diagnosis of anaphylaxis according to World Allergy Organization (WAO) 2020 criteria * Complete clinical data available in medical records Exclusion Criteria: * Incomplete or missing clinical data * Cases not meeting WAO 2020 anaphylaxis definition * Patients presenting with isolated urticaria or localized allergic reactions only

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anaphylaxis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anaphylaxis primary interstitial lung disease specific to childhood

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anaphylaxis Biphasic anaphylactic reaction Child Pediatric emergency care

More trials for these conditions

Other studies related to the condition(s) this trial covers.